It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Recent findings that a single dose of an H1N1 (swine) flu vaccine offers protection against the virus and anticipation of vaccination programs starting earlier than predicted will increase the number of people worldwide with access to the vaccine and the likelihood health officials may be able to control the spread of the virus, Bloomberg reports. "Manufacturing improvements and a single-dose vaccine may allow drugmakers to make enough vaccine to inoculate 3 billion people, said Marie-Paule Kieny, director of the World Health Organization's Initiative for Vaccine Research, in an e-mail," the news service writes.
Originally posted by fraterormus
That's interesting, because I read an article Friday on the C.D.C. website saying that the C.D.C. anticipates there being only up to 3.4 million vaccines available to United States citizens this Flu Season. That's about 301 million short to vaccinate everyone in the United States.
They are restricting this 3.4 million to people who live with or care for children younger than 6 months of age, healthcare and emergency medical services personnel, and people ages of 25 through 64 years of age who have chronic health disorders or compromised immune systems.
Although Children from 6-24 months of age and pregnant women are at higher risk, they are unable to take the inhaled vaccination. Those over 64 years of age are not at risk of H1N1 and are recommended not to get it, although the Seasonal Flu (Type A+B) vaccination is recommended for those over 64.
So, if the U.S. can only procure enough for 1% of our population, who is getting the lion's share of that 3 billion vaccinations the WHO is talking about? Who is manufacturing it, because it certainly isn't MedImmune because they have only been able to pump out 12 million vaccinations thus far.